Similar Papers

Paper Title
Journal
Date
Author
Nitric Oxide As a Mediator of Bone Marrow Fibrosis in Patients with Myelofibrosis
Ali Tabarroki ... Ramon V Tiu
Blood | VOL. 124
Ali Tabarroki, et. al.Ali Tabarroki ... Ramon V Tiu
06 Dec 2014
Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemia
Eda Tanrikulu Simsek ... Teoman Soysal
Blood | VOL. 126
Eda Tanrikulu Simsek, et. al.Eda Tanrikulu Simsek ... Teoman Soysal
03 Dec 2015
Effects of Long-Term Ruxolitinib (RUX) on Bone Marrow (BM) Morphology in Patients with Myelofibrosis (MF) Enrolled in the COMFORT-I Study
Hans Michael Kvasnicka ... Srdan Verstovsek
Blood | VOL. 128
Hans Michael Kvasnicka, et. al.Hans Michael Kvasnicka ... Srdan Verstovsek
02 Dec 2016
STAT3-Induced Gli1 Promotes the Differentiation and Maturation of Myelofibrosis Fibrocytes
Taghi Manshouri ... Zeev E Estrov
Blood | VOL. 134
Taghi Manshouri, et. al.Taghi Manshouri ... Zeev E Estrov
13 Nov 2019
View more papers

More From: Leukemia & Lymphoma

Paper Title
Journal
Date
Author
Indolent lymphoma: addressing the needs of survivors.
Pasquale L Fedele ... Stephen Opat
Leukemia & lymphoma | VOL. -
Pasquale L Fedele, et. al.Pasquale L Fedele ... Stephen Opat
28 Jan 2025
Matching-adjusted indirect comparisons of zanubrutinib (MAGNOLIA, BGB-3111-AU-003) versus ibrutinib (PCYC-1121) and rituximab (CHRONOS-3) in relapsed/refractory marginal zone lymphoma
Catherine Thieblemont ... Pier L Zinzani
Leukemia & Lymphoma | VOL. 66
Catherine Thieblemont, et. al.Catherine Thieblemont ... Pier L Zinzani
28 Jan 2025
Polatuzumab vedotin extravasation injury: a case report
Sushila A Toulmin ... Esther E Freeman
Leukemia & Lymphoma | VOL. ahead-of-print
Sushila A Toulmin, et. al.Sushila A Toulmin ... Esther E Freeman
24 Jan 2025
Presence of minimal residual disease determined by next-generation sequencing is not a reliable prognostic biomarker in children with acute lymphoblastic leukemia
Elizabeta Krstevska Bozhinovikj ... Aleksandar Dimovski
Leukemia & Lymphoma | VOL. ahead-of-print
Elizabeta Krstevska Bozhinovikj, et. al.Elizabeta Krstevska Bozhinovikj ... Aleksandar Dimovski
22 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.